Esperion Therapeutics
ESPR
ESPR
164 hedge funds and large institutions have $129M invested in Esperion Therapeutics in 2023 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 63 increasing their positions, 44 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
8.5% less ownership
Funds ownership: 99.69% → 91.19% (-8.5%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
72% less capital invested
Capital invested by funds: $458M → $129M (-$328M)
Holders
164
Holding in Top 10
1
Calls
$5.08M
Puts
$2.17M
Top Buyers
| 1 | +$10.3M | |
| 2 | +$5.85M | |
| 3 | +$2.94M | |
| 4 |
Millennium Management
New York
|
+$2.3M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$2.13M |
Top Sellers
| 1 | -$24.9M | |
| 2 | -$3.86M | |
| 3 | -$3.47M | |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$3.33M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$3.12M |